Who
Elias A. Zerhouni
Director
Company insider
Files Form 4 as: Director, Danaher; Vice Chairman and President, Opko Health.
In numbers
- Trades disclosed
- 141
- Buys
- 3
- Sells
- 2
- Bought
- $1.1M
- Sold
- $3.2M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 27 Jul 2010
- Last trade
- 31 Jul 2026
- Last filed
- 4 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 4 Aug 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $46K236.633 at $194.98 | filing |
| 31 Jul 2026filed 4 Aug 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $46K236.63 at $194.98 | filing |
| 15 Jul 2026filed 16 Jul 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code M | $237K3,298 at $71.88 | filing |
| 15 Jul 2026filed 16 Jul 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code F | $237K1,181 at $200.79 | filing |
| 15 Jul 2026filed 16 Jul 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code M | —3,298 at $0.00 | filing |
| 15 Jul 2026filed 16 Jul 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code M | —3,298 at $0.00 | filing |
| 15 Jul 2026filed 16 Jul 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code M | $237K3,298 at $71.88 | filing |
| 15 Jul 2026filed 16 Jul 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code F | $237K1,181 at $200.79 | filing |
| 15 May 2026filed 19 May 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —680 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | —1,699 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | —1,699 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —680 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $46K259.718 at $177.25 | filing |
| 24 Apr 2026filed 28 Apr 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $46K259.72 at $177.25 | filing |
| 30 Jan 2026filed 3 Feb 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $44K200.506 at $218.89 | filing |
| 30 Jan 2026filed 3 Feb 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $44K200.51 at $218.89 | filing |
| 31 Oct 2025filed 3 Nov 2025 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $44K203.47 at $215.38 | filing |
| 25 Jul 2025filed 28 Jul 2025 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $44K212.94 at $205.48 | filing |
| 15 Jul 2025filed 16 Jul 2025 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code M | —3,928 at $0.00 | filing |
| 15 Jul 2025filed 16 Jul 2025 | DHR DanaherLife-science tools | SEC FORM 4 Code M | $233K3,928 at $59.34 | filing |
News
Greenberg Traurig Advises OPKO Health on $722M+ Agreement to Sell Select BioReference Health Assets to LabcorpOPK · prnewswire.com · 21 Oct 2026Roper Technologies (ROP) vs. Danaher (DHR): Which Is the Better Long-Term Capital Allocator?DHR · insidermonkey.com · 18 Oct 2026Willow Creek Capital Management Inc. Purchases 2,796 Shares of Danaher Corporation $DHRDHR · dailypolitical.com · 17 Oct 2026Danaher's Stock Is Pricing in a Recovery. Can Its Earnings Deliver?DHR · insidermonkey.com · 16 Oct 2026Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthOPK · prnewswire.com · 15 Oct 2026
0 headlines in the last 90 days name Elias A. Zerhouni; 5 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.